1. Risk Factors for Development of Acute Kidney Injury in COVID-19 Patients: A Retrospective Observational Cohort Study
- Author
-
Yong Pey See, Li Wei Ang, Wan Limm Looi, Xi Yan Ooi, Chi Peng Chan, Barnaby Edward Young, David C. Lye, and See Cheng Yeo
- Subjects
Adult ,Male ,medicine.medical_specialty ,Drug-Related Side Effects and Adverse Reactions ,Comorbidity ,Cohort Studies ,Acute renal failure ,Risk Factors ,Vancomycin ,Interquartile range ,Chronic kidney disease ,Internal medicine ,Epidemiology ,medicine ,Humans ,Hypoxia ,Aged ,Retrospective Studies ,Clinical Practice: Research Article ,business.industry ,Anti-Inflammatory Agents, Non-Steroidal ,Age Factors ,Acute kidney injury ,COVID-19 ,Retrospective cohort study ,Odds ratio ,Acute Kidney Injury ,Middle Aged ,medicine.disease ,Anti-Bacterial Agents ,Treatment Outcome ,Creatinine ,Female ,business ,Kidney disease ,Cohort study - Abstract
Introduction: Acute kidney injury (AKI) in coronavirus infection disease (COVID-19) is associated with disease severity. We aimed to evaluate risk factors associated with AKI beyond COVID-19 severity. Methods: A retrospective observational study of COVID-19 patients admitted to a tertiary hospital in Singapore. Logistic regression was used to evaluate associations between risk factors and AKI (based on Kidney Disease Improving Global Outcomes criteria). Dominance analysis was performed to evaluate the relative importance of individual factors. Results: Seven hundred seven patients were included. Median age was 46 years (interquartile range [IQR]: 29–57) and 57% were male with few comorbidities (93%, Charlson Comorbidity Index [CCI] Conclusion: Severe COVID-19 is independently associated with increased risk of AKI beyond premorbid conditions and age. Appropriate avoidance of vancomycin and NSAIDs are potentially modifiable means to prevent AKI in patients with COVID-19.
- Published
- 2021
- Full Text
- View/download PDF